H.C. Wainwright raised the firm’s price target on Sensus Healthcare (SRTS) to $11 from $10 and keeps a Buy rating on the shares. The company reported a top- and bottom-line beat in Q3 amid strong momentum in the Fair Deal agreement, As previously reported,
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.